Mary H.H. Chandler

1.4k total citations
52 papers, 1.1k citations indexed

About

Mary H.H. Chandler is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health and Physiology. According to data from OpenAlex, Mary H.H. Chandler has authored 52 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmacology, 9 papers in Pediatrics, Perinatology and Child Health and 8 papers in Physiology. Recurrent topics in Mary H.H. Chandler's work include Antibiotics Pharmacokinetics and Efficacy (10 papers), Pharmaceutical Practices and Patient Outcomes (6 papers) and Analytical Methods in Pharmaceuticals (6 papers). Mary H.H. Chandler is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (10 papers), Pharmaceutical Practices and Patient Outcomes (6 papers) and Analytical Methods in Pharmaceuticals (6 papers). Mary H.H. Chandler collaborates with scholars based in United States. Mary H.H. Chandler's co-authors include Ken Muse, Mary Castiglia, Robert A. Blouin, B.A. Phillips, George A. Davis, William C. Stanley, G. Dennis Clifton, Robert J. Kuhn, Daniel E. Buffington and Taraneh Dean and has published in prestigious journals such as Diabetes Care, Biochemical and Biophysical Research Communications and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Mary H.H. Chandler

50 papers receiving 988 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary H.H. Chandler United States 17 277 201 185 136 131 52 1.1k
D. H. Lawson United Kingdom 22 139 0.5× 221 1.1× 140 0.8× 157 1.2× 176 1.3× 52 1.5k
G Cheymol France 19 155 0.6× 295 1.5× 491 2.7× 154 1.1× 248 1.9× 97 1.4k
Rocco C. Venuto United States 25 252 0.9× 209 1.0× 328 1.8× 527 3.9× 168 1.3× 103 2.1k
T Pullar United Kingdom 21 82 0.3× 226 1.1× 124 0.7× 202 1.5× 95 0.7× 51 1.5k
Laurence Galanti Belgium 19 309 1.1× 121 0.6× 386 2.1× 131 1.0× 241 1.8× 114 1.4k
T K Daneshmend United Kingdom 19 100 0.4× 252 1.3× 195 1.1× 101 0.7× 58 0.4× 42 1.5k
B.‐E. Wiholm Sweden 23 99 0.4× 217 1.1× 104 0.6× 233 1.7× 180 1.4× 35 1.7k
Charles E. Halstenson United States 22 80 0.3× 250 1.2× 163 0.9× 254 1.9× 113 0.9× 53 1.3k
Diane K. Jorkasky United States 27 138 0.5× 144 0.7× 425 2.3× 102 0.8× 341 2.6× 68 1.7k
Frederick C. Whittier United States 20 136 0.5× 76 0.4× 139 0.8× 108 0.8× 184 1.4× 51 1.5k

Countries citing papers authored by Mary H.H. Chandler

Since Specialization
Citations

This map shows the geographic impact of Mary H.H. Chandler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary H.H. Chandler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary H.H. Chandler more than expected).

Fields of papers citing papers by Mary H.H. Chandler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary H.H. Chandler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary H.H. Chandler. The network helps show where Mary H.H. Chandler may publish in the future.

Co-authorship network of co-authors of Mary H.H. Chandler

This figure shows the co-authorship network connecting the top 25 collaborators of Mary H.H. Chandler. A scholar is included among the top collaborators of Mary H.H. Chandler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary H.H. Chandler. Mary H.H. Chandler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hilt, Robert J., Christine Wolf, Kent M. Koprowicz, et al.. (2013). Community Child Psychiatric Medication Experiences Measured by an Internet-Based, Prospective Parent Survey of Retail Pharmacy Customers. Community Mental Health Journal. 50(2). 172–178. 1 indexed citations
2.
Barnes, Greta, Bo Li, Taraneh Dean, & Mary H.H. Chandler. (2000). Increased Optic Nerve Head Blood Flow After 1 Week of Twice Daily Topical Brinzolamide Treatment in Dutch-Belted Rabbits. Survey of Ophthalmology. 44. S131–S140. 35 indexed citations
3.
Leung, Kam H., et al.. (1998). Functional Effects of FGF-13 on Human Lung Fibroblasts, Dermal Microvascular Endothelial Cells, and Aortic Smooth Muscle Cells. Biochemical and Biophysical Research Communications. 250(1). 137–142. 9 indexed citations
4.
Chandler, Mary H.H., et al.. (1997). Premenstrual asthma: the effect of estrogen on symptoms, pulmonary function, and beta 2-receptors.. PubMed. 17(2). 224–34. 106 indexed citations
5.
Davis, George A., et al.. (1997). General versus subpopulation values in Bayesian prediction of aminoglycoside pharmacokinetics in hematology-oncology patients. American Journal of Health-System Pharmacy. 54(5). 541–544. 3 indexed citations
6.
Pestotnik, Stanley L., et al.. (1996). Integrating Pharmacokinetics into Point-of-Care Information Systems. Clinical Pharmacokinetics. 31(3). 165–173. 8 indexed citations
7.
Chandler, Mary H.H., et al.. (1995). Pharmacokinetic Optimisation of Vancomycin Therapy. Clinical Pharmacokinetics. 28(4). 327–342. 131 indexed citations
8.
Iga, Tatsuji, et al.. (1994). Health care and institutional pharmacy practice in Japan. American Journal of Health-System Pharmacy. 51(4). 535–538. 5 indexed citations
9.
Kuhn, Robert J., et al.. (1994). Pharmacokinetics of Anti-Infective Agents in Paediatric Patients. Clinical Pharmacokinetics. 26(5). 374–395. 33 indexed citations
10.
Kearney, Paul A., et al.. (1993). ONCE-DAILY AMINOGLYCOSIDES. The Journal of Trauma: Injury, Infection, and Critical Care. 35(6). 981–981. 10 indexed citations
11.
Chandler, Mary H.H., et al.. (1993). Predicting vancomycin pharmacokinetics by using aminoglycoside pharmacokinetics.. PubMed. 12(12). 909–13. 6 indexed citations
12.
Clifton, G. Dennis, et al.. (1992). Differential response of β-adrenergic receptor—mediated heart rate and aortic blood flow acceleration to timolol. Clinical Pharmacology & Therapeutics. 51(3). 296–301. 1 indexed citations
13.
McIntyre, W, et al.. (1992). Pharmacokinetics of ondansetron in patients receiving cisplatin therapy.. PubMed. 11(12). 1026–9. 1 indexed citations
14.
Hamelin, Bettina A., Robert A. Blouin, Karen Wolf, G. Dennis Clifton, & Mary H.H. Chandler. (1992). In Vivo and In Vitro β2‐Adrenergic Receptor Responsiveness in Young and Elderly Asthmatics. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 12(5). 376–382. 9 indexed citations
15.
Porter, William H., et al.. (1990). Severe Phenytoin Intoxication as a Result of Altered Protein Binding in Aids. DICP. 24(7-8). 698–700. 16 indexed citations
16.
Chandler, Mary H.H., et al.. (1990). Pulmonary Function in the Elderly: Response to Theophylline Bronchodilation. The Journal of Clinical Pharmacology. 30(4). 330–335. 9 indexed citations
17.
Colangelo, Philip M., Mary H.H. Chandler, Robert A. Blouin, & Patrick J. McNamara. (1989). Stereoselective binding of propranolol in the elderly.. British Journal of Clinical Pharmacology. 27(4). 519–522. 12 indexed citations
18.
Clifton, G. Dennis, W McIntyre, Peter Zannikos, Michael R. Harrison, & Mary H.H. Chandler. (1989). Free and total serum digoxin concentrations in a renal failure patient after treatment with digoxin immune Fab.. PubMed. 8(6). 441–5. 7 indexed citations
19.
Chandler, Mary H.H., Horst Schran, Ralph E. Cutler, et al.. (1988). The Effects of Renal Function on the Disposition of Isradipine. The Journal of Clinical Pharmacology. 28(12). 1076–1080. 16 indexed citations
20.
Chandler, Mary H.H., et al.. (1988). Age-associated stereoselective alterations in hexobarbital metabolism. Clinical Pharmacology & Therapeutics. 43(4). 436–441. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D. H. Lawson Breakdown of academic impact, for papers by G Cheymol Breakdown of academic impact, for papers by Rocco C. Venuto Breakdown of academic impact, for papers by T Pullar Breakdown of academic impact, for papers by Laurence Galanti Breakdown of academic impact, for papers by T K Daneshmend Breakdown of academic impact, for papers by B.‐E. Wiholm Breakdown of academic impact, for papers by Charles E. Halstenson Breakdown of academic impact, for papers by Diane K. Jorkasky Breakdown of academic impact, for papers by Frederick C. Whittier
Rankless by CCL
2026